✦ LIBER ✦

PMS44 Cost-Effectiveness of Denosumab in the Treatment of Postmenopausal Osteoporosis in Scotland

✍ Scribed by A. Davies; J. Compston; S. Ferguson; E. McClosky; A. Shearer; A. Taylor

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cost-effectiveness of Denosumab for the

✍ B. Jönsson; O. Ström; J. A. Eisman; A. Papaioannou; E. S. Siris; A. Tosteson; J. 📂 Article 📅 2010 🏛 Springer-Verlag 🌐 English ⚖ 336 KB

Cost-effectiveness of denosumab in the t

✍ Chau, D.; Becker, D. L.; Coombes, M. E.; Ioannidis, G.; Adachi, J. D.; Goeree, R 📂 Article 📅 2012 🏛 Informa plc 🌐 English ⚖ 282 KB

PMS48 Cost-Utility of Denosumab for the

✍ J. Darba; L. Kaskens; F. Sorio 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

Comment on: cost-effectiveness of denosu

✍ B. Jönsson, O. Ström, J. A. Eisman, A. Papaioannou, E. S. Siris, A. Tosteson, J. 📂 Article 📅 2011 🏛 Springer-Verlag 🌐 English ⚖ 166 KB

PMS40 Cost-Effectiveness of Denosumab fo

✍ A. Parthan; M.M. Deflin; I. Agodoa; C.Y. Tao; S.L. Silverman; E. Orwoll 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB

PMS35 A Cost-Effectiveness Analysis of D

✍ K. Athanasakis; E. Karampli; M. Hollandezos; V. Papagiannopoulou; E. Badamgarav; 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB